Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CRVS · NASDAQ · Pharmaceutical Preparations
Corvus Pharmaceuticals (CRVS) · oqro.io/stocks/CRVS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$10.64+0.02 (+0.19%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 12, 2026 · Filed Nov 13, 2026
Officer purchased ~$5.5K of CRVS shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
Officer purchased ~$5.2K of CRVS shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
Officer purchased ~$5.4K of CRVS shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Officer purchased ~$34K of CRVS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed an increased position in CRVS for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed an increased position in CRVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a new position in CRVS for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed a reduced position in CRVS for Q4 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed an increased position in CRVS for Q2 2025SourceInsider trade · Traded Jun 27, 2025 · Filed Jul 2, 2025
Director sold ~$4.89M of CRVS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 2, 2025
Director sold ~$4.89M of CRVS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Samlyn Capital, LLC disclosed a reduced position in CRVS for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Samlyn Capital, LLC disclosed an increased position in CRVS for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Samlyn Capital, LLC disclosed a reduced position in CRVS for Q3 2024Source